NO177596C - Cancerassosiert SCM-gjenkjenningsfaktor, fremstilling og anvendelse - Google Patents

Cancerassosiert SCM-gjenkjenningsfaktor, fremstilling og anvendelse

Info

Publication number
NO177596C
NO177596C NO884919A NO884919A NO177596C NO 177596 C NO177596 C NO 177596C NO 884919 A NO884919 A NO 884919A NO 884919 A NO884919 A NO 884919A NO 177596 C NO177596 C NO 177596C
Authority
NO
Norway
Prior art keywords
cancer
preparation
recognition factor
associated scm
scm recognition
Prior art date
Application number
NO884919A
Other languages
English (en)
Norwegian (no)
Other versions
NO177596B (no
NO884919L (no
NO884919D0 (no
Inventor
Boris Cercek
Lea Cercek
Original Assignee
Boris Cercek
Lea Cercek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boris Cercek, Lea Cercek filed Critical Boris Cercek
Publication of NO884919D0 publication Critical patent/NO884919D0/no
Publication of NO884919L publication Critical patent/NO884919L/no
Publication of NO177596B publication Critical patent/NO177596B/no
Publication of NO177596C publication Critical patent/NO177596C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6845Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4745Cancer-associated SCM-recognition factor, CRISPP
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO884919A 1987-03-06 1988-11-04 Cancerassosiert SCM-gjenkjenningsfaktor, fremstilling og anvendelse NO177596C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2275987A 1987-03-06 1987-03-06
PCT/US1988/000568 WO1988006595A1 (fr) 1987-03-06 1988-03-04 Facteur general de reconnaissance de structuration de matrice cytoplasmique (scm) associe au cancer, preparation et methode d'utilisation

Publications (4)

Publication Number Publication Date
NO884919D0 NO884919D0 (no) 1988-11-04
NO884919L NO884919L (no) 1989-01-05
NO177596B NO177596B (no) 1995-07-10
NO177596C true NO177596C (no) 1995-10-18

Family

ID=21811282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884919A NO177596C (no) 1987-03-06 1988-11-04 Cancerassosiert SCM-gjenkjenningsfaktor, fremstilling og anvendelse

Country Status (10)

Country Link
EP (1) EP0357637B1 (fr)
KR (1) KR890700605A (fr)
AU (1) AU624071B2 (fr)
CA (1) CA1336404C (fr)
DE (1) DE3872235T2 (fr)
DK (1) DK616188A (fr)
FI (1) FI92832C (fr)
IL (1) IL85645A0 (fr)
NO (1) NO177596C (fr)
WO (1) WO1988006595A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270171A (en) * 1987-03-06 1993-12-14 Boris Cercek Cancer-associated SCM-recognition factor, preparation and method of use
US5580561A (en) * 1987-03-06 1996-12-03 Cercek; Boris Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
US5516643A (en) * 1987-03-06 1996-05-14 Cercek; Boris Immunochemical assays for cancer-associated SCM-recognition factor
JPH03503763A (ja) * 1988-03-11 1991-08-22 サーセク・ボリス 一般的な癌‐関連scm‐認識因子、調製品及び使用方法

Also Published As

Publication number Publication date
WO1988006595A1 (fr) 1988-09-07
AU624071B2 (en) 1992-06-04
FI92832B (fi) 1994-09-30
IL85645A0 (en) 1988-08-31
FI92832C (fi) 1995-01-10
NO177596B (no) 1995-07-10
DE3872235D1 (de) 1992-07-23
NO884919L (no) 1989-01-05
AU1595188A (en) 1988-09-26
FI894220A0 (fi) 1989-09-06
CA1336404C (fr) 1995-07-25
NO884919D0 (no) 1988-11-04
DK616188D0 (da) 1988-11-04
DK616188A (da) 1988-11-04
KR890700605A (ko) 1989-04-26
DE3872235T2 (de) 1992-12-03
EP0357637B1 (fr) 1992-06-17
EP0357637A1 (fr) 1990-03-14

Similar Documents

Publication Publication Date Title
DK122687D0 (da) Polypeptid, dna og anvendelse deraf
DK129386D0 (da) Iodpropargylethere, deres fremstilling og anvendelse
NO860664L (no) Roer og fremgangsmaate for fremstilling av samme.
DK354687D0 (da) 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse
DK519586A (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK535287A (da) Piperidin-4-yl-tetracycliske benzodiazepiner, deres fremstilling og anvendelse
DK451786A (da) Transglucosidase, fremstilling og anvendelse deraf
DK296687D0 (da) N-1h-tetrazol-5-yl-2-thiophen-carboxamider, n-1h-tetrazol-5-yl-2-pyrrol-carboxamider og n-1h-tetrazol-5-yl-2-furan-carboxamider
EP0188259A3 (en) Benzotriazoles, and their production and use
DK380286D0 (da) Sulfonamider, deres fremstilling og anvendelse
NO177596C (no) Cancerassosiert SCM-gjenkjenningsfaktor, fremstilling og anvendelse
FI864566A7 (fi) Nitroantrasykliinit, niiden valmistusmenetelmä ja niiden käyttö.
DK617886A (da) 1-aryl-pyrazoler, deres fremstilling og anvendelse
DK396886A (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
KR870004977A (ko) 2,2'-바이-1h-이미다졸 및 그의 제조방법
DK674587D0 (da) Anti-forkoelelses-kit, anti-forkoelelsespraeparat og anvendelse deraf
DK377786A (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
EP0274066A3 (en) Benzothiazolones, and their production and use
DK516587D0 (da) Parenterale depotpraeparater, deres fremstilling og anvendelse
DK126987D0 (da) Pyrimidoindoler, deres fremstilling og anvendelse
ES2011776B3 (es) Colorantes reactivos, su preparacion y su empleo.
EP0258773A3 (en) Benzothiazolones, and their production and use
DK393986A (da) Lactamamider, deres fremstilling og anvendelse
DK451486A (da) Alkenylazoler, deres fremstilling og anvendelse